Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio
admin2022-02-16T10:16:41+00:00Company to commercialize and create single-cell multi-omics products SEATTLE--(BUSINESS WIRE)--Feb. 15, 2022 Parse Biosciences,